近期论文

查看导师新发文章 （温馨提示：请注意重名现象，建议点开原文通过作者单位确认）

Houshmandyar, S., Reelfs, O., Radka, T., Eggleston, I. and Pourzand, C., 2016. Clinical Iron Chelators For Skin Photoprotection As Light-Activated Caged Iron Chelators. Houshmandyar, S., Reelfs, O., Radka, T., Eggleston, I. and Pourzand, C., 2016. Deferiprone And Deferasirox As Promissing Candidate Ligands For Skin Photoprotection By Light-Activated Caged-Iron Chelators. American Journal of Hematology, 91 (3), E69-E69. Godfrey, S., Sarpaki, S., Mirabello, V., Eggleston, I. and Pascu, S., 2016. Design and synthesis of porphyrin-based metal complexes for multimodal bioimaging. Journal of Labelled Compounds & Radiopharmaceuticals, 59 (4), p. 183. Taverner, A., Dondi, R., Almansour, K., Laurent, F., Owens, S.-E., Eggleston, I. M., Fotaki, N. and Mrsny, R. J., 2015. Enhanced paracellular transport of insulin can be achieved via transient induction of myosin light chain phosphorylation. Journal of Controlled Release, 210, pp. 189-197. Alade, A., Yaghini, E., Dondi, R., Eggleston, I. and MacRobert, A. J., 2015. The cell-penetrating peptide chlorin conjugate, a novel class of photosensitiser for photodynamic therapy and photochemical internalisation. British Journal of Surgery, 102, p. 36. Hu, Z., Arrowsmith, R. L., Tyson, J. A., Mirabello, V., Ge, H., Eggleston, I. M., Botchway, S. W., Pantos, D. and Pascu, S. I., 2015. A fluorescent Arg–Gly–Asp (RGD) peptide–naphthalenediimide (NDI) conjugate for imaging integrin αvβ3in vitro. Chemical Communications, 51 (32), pp. 6901-6904. Di Venosa, G., Vallecorsa, P., Giuntini, F., Mamone, L., Batlle, A., Vanzuli, S., Juarranz, A., MacRobert, A. J., Eggleston, I. M. and Casas, A., 2015. The use of dipeptide derivatives of 5-aminolaevulinic acid promotes their entry to tumor cells and improves tumor selectivity of photodynamic therapy. Molecular Cancer Therapeutics, 14 (2), pp. 440-451. Reelfs, O., Young, B., Radka, T., Eggleston, I. and Pourzand, C., 2014. A novel generation of photoactivatable caged-iron chelators with both antioxidant and iron chelation properties for skin photoprotection. In: European Iron Club 2014, 2014-09-11 - 2014-09-14. Radka, T., Reelfs, O., Dondi, R., Eggleston, I. and Pourzand, C., 2014. UVA-activatable caged iron chelators significantly improve the efficiency of topical aminolevulinate-based photodynamic therapy of skin cancer. Yaghini, E., Giuntini, F., Eggleston, I. M., Suhling, K., Seifalian, A. M. and MacRobert, A. J., 2014. Fluorescence lifetime imaging and FRET-induced intracellular redistribution of tat-conjugated quantum dot nanoparticles through interaction with a phthalocyanine photosensitiser. Small, 10 (4), pp. 782-792. Jolly, P., Formisano, N., Djahanbakhsh Rafiee, S., Bhalla, N., Miodek, A., Dondi, R., Yang, D. K., Chen, L.C., Kasak, P., Tkac, J., Lloyd, M. D., Eggleston, I. M. and Estrela, P., 2014. DNA aptamer-based approaches for detection of multiple prostate cancer biomarkers. In: 22nd Meeting of the EAU Section of Urological Research (ESUR), 2014, 2014-10-09 - 2014-10-11. Arrowsmith, R., Kociok-Kohn, G., Eggleston, I., Tyrrell, R., Dilworth, J. R., Aigbirhio, F. I. and Pascu, S., 2014. Intrinsically fluorescent bis(thiosemicarbazonates) with high kinetic stability in biological environments: synthetic scaffolds for optical/PET or SPECT dual-modality imaging agent. Journal of Labelled Compounds & Radiopharmaceuticals, 57 (3), pp. 189-190. Pourzand, Charareh, 2014. Preparation of UV radiation cleavable compounds. PCT Int. Appl.- WO 2014041362, 2014. Reelfs, O., Young, B., Aroun, A., Hoffmann, M., Miri, S. A., Richardson, D. R., Eggleston, I. and Pourzand, C., 2013. A comparative study of the antiprolifrative activity of thiosemicarbazone iron chelators in skin cells. American Journal of Hematology, 88 (5), E170-E170. Radka, T., Reelfs, O., Dondi, R., Eggleston, I. and Pourzand, C., 2013. Improving the efficiency of aminolevulinate-photodynamic therapy of skin cancer by combining uva irradiation and potent iron chelating agents. American Journal of Hematology, 88 (5), E170-E171. Young, B., Reelfs, O., Aroun, A., Eggleston, I. and Pourzand, C., 2013. Light-activatable and photo-controlled caged-nih, a promising pro-iron chelator for the topical therapy of skin cancer. American Journal of Hematology, 88 (5), E177-E177. Young, B., Reelfs, O., Aroun, A., Miri, S. A., Hoffmann, M., Pourzand, C. and Eggleston, I., 2013. Novel light-activated caged iron chelators: targeted prodrugs for iron related-disorders. American Journal of Hematology, 88 (5), E176-E176. Schimpl, M., Rush, C. l., Betou, M., Eggleston, I. M., Recklies, A. d. and Van aalten, D. m. F., 2012. Human YKL-39 is a pseudo-chitinase with retained chitooligosaccharide-binding properties. Biochemical Journal, 446 (1), pp. 149-157. Wang, J. T. -W., Giuntini, F., Eggleston, I. M., Bown, S. G. and MacRobert, A. J., 2012. Photochemical internalisation of a macromolecular protein toxin using a cell penetrating peptide-photosensitiser conjugate. Journal of Controlled Release, 157 (2), pp. 305-313. van Aalten, Daan M. F., 2012. New xanthine compounds useful as aspergillus fumigatus chitinase B1 inhibitors to prevent/treat e.g. asthma, autoimmune disease and fungal infections. WO2006136822-A1; EP1893614-A1; JP2008546752-W; US2009215798-A1; US8207175-B2; EP1893614-B1, 2012.